Abstract
Objectives
This study aimed to examine the IL-1β, IL-1ra, and IL-10 cytokine levels in gingival crevicular fluid (GCF) and serum of familial Mediterranean fever (FMF) and chronic periodontitis (CP) patients, and their response to nonsurgical periodontal therapy.
Materials and methods
A total of 50 patients, 15 FMF patients with generalized chronic periodontitis (FMF-CP), 15 systemically healthy patients with generalized chronic periodontitis (CP), ten systemically and periodontal healthy controls (HC), and ten periodontally healthy FMF patients (FMF-HC) were enrolled in the study. The cytokine levels in GCF and serum were determined by ELISA. Probing depth, clinical attachment level, and gingival and plaque indices in each participant were also measured. The GCF and clinical parameters at baseline and 6 weeks were recorded.
Results
The study indicated statistically significant healing of the clinical parameters in both FMF-CP and CP groups after periodontal treatment. GCF IL-1β levels at 6 weeks in FMF-CP group were significantly lower than the CP group (p < 0.05), and GCF IL-1ra levels were significantly decreased at 6 week in the FMF-CP group (p < 0.05). GCF IL-10 levels were significantly higher in the FMF-CP group than in the other groups at baseline and 6 weeks (p < 0.05). There were no significant differences in serum-IL-1β, IL-1ra, and IL-10 levels either FMF-CP or CP groups at baseline or 6 weeks (p > 0.05).
Conclusions
The results of our study suggested that there was a positive correlation between gingival inflammation and serum cytokine levels in FMF patients and also colchicine treatment showed protective effects on GCF cytokine levels in FMF-CP group.
Clinical relevance
Following treatment, GCF IL-1β and GCF IL-1ra levels were decreased in FMF-CP group. GCF IL-10 levels were increased in FMF-CP group compared to other groups. Also, the serum cytokine levels associated with periodontal inflammation in FMF patients.
Similar content being viewed by others
References
Kornman KS (2008) Mapping the pathogenesis of periodontitis: a new look. J Periodontol 79:1560–1568
Toygar HU, Seydaoglu G, Kurklu S, Guzeldemir E, Arpak N (2007) Periodontal health and adverse pregnancy outcome in 3,576 Turkish women. J Periodontol 78:2081–2094
Pan Z, Guzeldemir E, Toygar HU, Bal N, Bulut S (2010) Nitric oxide synthase in gingival tissues of patients with chronic periodontitis and with and without diabetes. J Periodontol 81:109–120
Oe Y, Soejima H, Nakayama H, Fukunaga T, Sugamura K, Kawano H, Sugiyama S, Matsuo K, Shinohara M, Izumi Y, et al. (2009) Significant association between score of periodontal disease and coronary artery disease. Heart Vessel 24:103–107
Sharma N, Shamsuddin H (2011) Association between respiratory disease in hospitalized patients and periodontal disease: a cross-sectional study. J Periodontol 82:1155–1160
Detert J, Pischon N, Burmester GR, Buttgereit F (2010) The association between rheumatoid arthritis and periodontal disease. Arthritis Res Ther 12:218
Cochran DL (2008) Inflammation and bone loss in periodontal disease. J Periodontol 79:1569–1576
Mercado FB, Marshall RI, Klestov AC, Bartold PM (2001) Relationship between rheumatoid arthritis and periodontitis. J Periodontol 72:779–787
Soory M (2007) Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention? Curr Drug Metab 8:750–757
Yavuzyilmaz E, Yamalik N, Bulut S, Ozen S, Ersoy F, Saatci U (1995) The gingival crevicular fluid interleukin-1 beta and tumour necrosis factor-alpha levels in patients with rapidly progressive periodontitis. Aust Dent J 40:46–49
Tsai CC, Ho YP, Chen CC (1995) Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 66:852–859
Ishihara Y, Nishihara T, Kuroyanagi T, Shirozu N, Yamagishi E, Ohguchi M, Koide M, Ueda N, Amano K, Noguchi T (1997) Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites. J Periodontal Res 32:524–529
Giannopoulou C, Kamma JJ, Mombelli A (2003) Effect of inflammation, smoking and stress on gingival crevicular fluid cytokine level. J Clin Periodontol 30:145–153
Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106–113
Tatakis DN (1993) Interleukin-1 and bone metabolism: a review. J Periodontol 64:416–431
Rawlinson A, Dalati MH, Rahman S, Walsh TF, Fairclough AL (2000) Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol 27:738–743
Rawlinson A, Grummitt JM, Walsh TF, Ian Douglas CW (2003) Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers. J Clin Periodontol 30:42–48
Yoshinari N, Kawase H, Mitani A, Ito M, Sugiishi S, Matsuoka M, Shirozu N, Ishihara Y, Bito B, Hiraga M, et al. (2004) Effects of scaling and root planing on the amounts of interleukin-1 and interleukin-1 receptor antagonist and the mRNA expression of interleukin-1beta in gingival crevicular fluid and gingival tissues. J Periodontal Res 39:158–167
Al-Rasheed A, Scheerens H, Rennick DM, Fletcher HM, Tatakis DN (2003) Accelerated alveolar bone loss in mice lacking interleukin-10. J Dent Res 82:632–635
de Waal Malefyt R, Yssel H, de Vries JE (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150:4754–4765
Hirose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K (2001) Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol 72:590–597
Drenth JP, van der Meer JW (2001) Hereditary periodic fever. N Engl J Med 345:1748–1757
Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, et al. (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11
Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H (2004) Increased frequency of familial Mediterranean fever in Central Anatolia, Turkey. Clin Exp Rheumatol 22:S31–S33
Yenokyan G, Armenian HK (2012) Triggers for attacks in familial Mediterranean fever: application of the case-crossover design. Am J Epidemiol 175:1054–1061
Sari I, Karaoglu O, Can G, Akar S, Gulcu A, Birlik M, Akkoc N, Tunca M, Goktay Y, Onen F (2007) Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever. Clin Rheumatol 26:1467–1473
Ozcakar ZB, Yalcinkaya F, Yuksel S, Acar B, Gokmen D, Ekim M (2006) Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25:149–152
Baykal Y, Saglam K, Yilmaz MI, Taslipinar A, Akinci SB, Inal A (2003) Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 22:99–101
Erken E, Gunesacar R, Ozbek S, Konca K (1996) Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 55:852–855
Oktem S, Yavuzsen TU, Sengul B, Akhunlar H, Akar S, Tunca M (2004) Levels of interleukin-6 (IL-6) and its soluble receptor (sIL-6R) in familial Mediterranean fever (FMF) patients and their first degree relatives. Clin Exp Rheumatol 22:S34–S36
Direskeneli H, Ozdogan H, Korkmaz C, Akoglu T, Yazici H (1999) Serum soluble intercellular adhesion molecule 1 and interleukin 8 levels in familial Mediterranean fever. J Rheumatol 26:1983–1986
Sezer U, Senyurt SZ, Ozdemir EC, Zengin O, Ustun K, Erciyas K, Kisacik B, Onat AM (2015) Relationship between periodontal destruction and gene mutations in patients with familial Mediterranean fever. Clin Rheumatol doi:10.1007/s10067-015-3078-8
Bostanci V, Toker H, Senel S, Sahin S (2014) Prevalence of periodontal disease in patients with Familial Mediterranean Fever: a cohort study from Central Turkey. Quintessence Int 45:743–748
Bostanci V, Toker H, Senel S, Ozdemir H, Aydin H (2014) Effect of chronic periodontitis on serum and gingival crevicular fluid oxidant and antioxidant status in patients with familial Mediterranean fever before and after periodontal treatment. J Periodontol 85:706–712
Armitage GC (1999) Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4:1–6
Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885
Loe H (1967) The gingival index, the plaque index and the retention index systems. J Periodontol 38(Suppl):610–616
Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2000) Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71:1535–1545
Toker H, Poyraz O, Eren K (2008) Effect of periodontal treatment on IL-1beta, IL-1ra, and IL-10 levels in gingival crevicular fluid in patients with aggressive periodontitis. J Clin Periodontol 35:507–513
Figueredo CM, Ribeiro MS, Fischer RG, Gustafsson A (1999) Increased interleukin-1beta concentration in gingival crevicular fluid as a characteristic of periodontitis. J Periodontol 70:1457–1463
Alexander DC, Martin JC, King PJ, Powell JR, Caves J, Cohen ME (1996) Interleukin-1 beta, prostaglandin E2, and immunoglobulin G subclasses in gingival crevicular fluid in patients undergoing periodontal therapy. J Periodontol 67:755–762
Biyikoglu B, Buduneli N, Aksu K, Nalbantsoy A, Lappin DF, Evrenosoglu E, Kinane DF (2013) Periodontal therapy in chronic periodontitis lowers gingival crevicular fluid interleukin-1beta and DAS28 in rheumatoid arthritis patients. Rheumatol Int 33:2607–2616
Saglam M, Kantarci A, Dundar N, Hakki SS (2014) Clinical and biochemical effects of diode laser as an adjunct to nonsurgical treatment of chronic periodontitis: a randomized, controlled clinical trial. Lasers Med Sci 29:37–46
Goutoudi P, Diza E, Arvanitidou M (2004) Effect of periodontal therapy on crevicular fluid interleukin-1beta and interleukin-10 levels in chronic periodontitis. J Dent 32:511–520
Yildirim K, Uzkeser H, Keles M, Karatay S, Kiziltunc A, Kaya MD, Yildirim A (2012) Relationship between serum interleukin-1beta levels and acute phase response proteins in patients with familial Mediterranean fever. Biochem Med (Zagreb) 22:109–113
Gang N, Drenth JP, Langevitz P, Zemer D, Brezniak N, Pras M, van der Meer JW, Livneh A (1999) Activation of the cytokine network in familial Mediterranean fever. J Rheumatol 26:890–897
Birkedal-Hansen H (1993) Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 28:500–510
Drenth JP, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JW (1995) Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 85:3586–3593
Marques-da-Silva C, Chaves MM, Castro NG, Coutinho-Silva R, Guimaraes MZ (2011) Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action. Br J Pharmacol 163:912–926
Bagci S, Toy B, Tuzun A, Ates Y, Aslan M, Inal A, Gulsen M, Karaeren N, Dagalp K (2004) Continuity of cytokine activation in patients with familial Mediterranean fever. Clin Rheumatol 23:333–337
Musabak U, Sengul A, Oktenli C, Pay S, Yesilova Z, Kenar L, Sanisoglu SY, Inal A, Tuzun A, Erdil A, et al. (2004) Does immune activation continue during an attack-free period in familial Mediterranean fever? Clin Exp Immunol 138:526–533
Erken E, Ozer HT, Gunesacar R (2006) Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatol Int 26:862–864
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study was funded by the Scientific Research Cumhuriyet University under the project number Dis-124.
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Bostanci, V., Toker, H., Senel, S. et al. Evaluation of IL-1β, IL-1ra, and IL-10 levels and outcome of periodontal therapy in chronic periodontitis with familial Mediterranean fever. Clin Oral Invest 21, 469–475 (2017). https://doi.org/10.1007/s00784-016-1816-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-016-1816-1